Wird geladen...
Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors
BACKGROUND: Both endometrial cancer and postmenopausal breast cancer risk are increased by obesity and higher endogenous estrogen levels. While aromatase inhibitors reduce breast cancer incidence, their influence on endometrial cancer is uncertain. METHODS: We addressed this issue in a cohort of 17,...
Gespeichert in:
| Veröffentlicht in: | Cancer |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565775/ https://ncbi.nlm.nih.gov/pubmed/25757699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29332 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|